P2Y12 receptor inhibitor
This page covers all P2Y12 receptor inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting P2Y12.
Targets
Phase 3 pipeline (1)
- The ticagrelor · Sichuan Provincial People's Hospital · Cardiovascular
Ticagrelor is a platelet aggregation inhibitor that works by blocking the P2Y12 receptor.
Patent intelligence
- p2y12 receptor inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates